The objective of this session is to address the question how hypervolemia can increase the mortality rate in sepsis patients by looking at the desired and undesired effects fluids can have, as well as the diagnosis and management of hypervolemia in general. The question whether the early use of vasopressors can avoid hypervolemia, safety limits, and how fluids can be removed are also addressed.

Agenda:

• Desired and Undesired Effects of Fluids
• Diagnosis and Management of Hypervolemia in Sepsis
• Can Early Use of Vasopressors Avoid Hypervolemia?
• The Safety Limits to Stop Fluid Infusions
• Fluid Removal: When and How?

The speakers are internationally-recognized experts chosen by the World Sepsis Alliance Scientific Advisor Committee:

• Naomi Hammond, Asia Pacific Sepsis Alliance, Australia
• Manu Malbrain, International Fluid Academy, Poland
• Sheila Myatra, Asia Pacific Sepsis Alliance, India
• Jean-Louis Teboul, University Paris-Saclay, France
• Ludhmila Hajjar, University of São Paulo, Brazil
• Marlies Ostermann, Guy’s and St Thomas’ NHS Foundation Trust, United Kingdom